Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,522.00
(
0.33%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,483.76
(
0.16%
)
News Focus
News Focus
Post# of 20617
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Biotech Pharmer

Send PM Follow Ignore
Followers 0
Posts 1521
Boards Moderated 0
Alias Born 09/16/2005

Biotech Pharmer

Re: None

Thursday, 08/10/2017 8:31:32 AM

Thursday, August 10, 2017 8:31:32 AM

Post# of 20617
"The Company ordered one batch of the drug from its partner West-Ward for Q4 2017 and has committed multiple batches for 2018 and 2019." OK, so answer this: Why would Damaj COMMIT to 2018 and 2019 batches from Hikma if they're confident that the original ANDA is coming through? And save the "they'll need 2 to keep up with demand" argument, because that's total BS.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today